2U3:FRA
Alcon AG
56,12 €
arrow_downward
-1,47%(-0,84) 1 d.
6. okt., 22:00:00 GMT+2 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 2U3…
Atvērt
56,50 €
Augsta
57,00 €
Zema
56,12 €
Tirgus kapitalizācija
26,27 mljrd.
Vid. apjoms
210,00
Apjoms
56,00
Augstākā 52 ned.
73,96 €
Zemākā 52 ned.
51,78 €
Darbinieku skaits
25 tūkst.
Atvērt
56,50 €
Augsta
57,00 €
Zema
56,12 €
Tirgus kapitalizācija
26,27 mljrd.
Vid. apjoms
210,00
Apjoms
56,00
Augstākā 52 ned.
73,96 €
Zemākā 52 ned.
51,78 €
Darbinieku skaits
25 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
AD HOC NEWS
·
pirms 1 dienas
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
AD HOC NEWS
·
pirms 1 dienas
Alcon stock gets a new weekly lens launch in October 2026
AD HOC NEWS
·
pirms 1 dienas
Alcon announces Academy research. Alcon stock sits 23.02 percent below its 52-week high
AD HOC NEWS
·
pirms 1 dienas
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profils
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Par “Alcon AG”
ĢenerāldirektorsDavid J. Endicott
Darbinieki25 tūkst.
Dibināšanas datums1945
Galvenais birojsŽenēva, Ženēva, Šveice
Sektors-
Tīmekļa vietnealcon.com